Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/51742
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA |
Author: | McIntyre, C. Derrick Roberts, A. Ranieri, E. Clements, P. Byers, S. Anson, D. |
Citation: | Molecular Genetics and Metabolism, 2008; 93(4):411-418 |
Publisher: | Academic Press Inc Elsevier Science |
Issue Date: | 2008 |
ISSN: | 1096-7192 1096-7206 |
Statement of Responsibility: | Chantelle McIntyre, Ainslie Lauren Derrick Roberts, Enzo Ranieri, Peter Roy Clements, Sharon Byers and Donald S. Anson |
Abstract: | Mucopolysaccharidosis type IIIA (MPS IIIA) is a heritable glycosaminoglycan (GAG) storage disorder which is characterised by lysosomal accumulation of heparan sulphate, secondary to a deficiency of sulphamidase (heparan-N-sulphatase, N-sulphoglucosamine sulphohydrolase, EC No. 3.10.1.1.). There is currently no treatment for affected individuals who experience progressive CNS deterioration prior to an early death. As a first step towards developing gene therapy as a treatment for MPS IIIA, an MPS IIIA mouse model was used to examine the efficacy of intravenous lentiviral-mediated gene therapy. Five-week-old mice were injected with virus expressing murine sulphamidase and analysed 6 months after treatment. Transduction by the lentiviral vector was highest in the liver and spleen of treated animals, and sulphamidase activity in these tissues averaged 68% and 186% of normal, respectively. Storage was assessed using histochemical, chemical and mass spectrometric analyses. Storage in most somatic tissues was largely normalised, although chondrocytes were an obvious exception. Histologically, improvement of lysosomal storage within the brain was variable. However, beta-hexosaminidase activity, which is abnormally elevated in MPS IIIA, was significantly reduced in every treated tissue, including the brain. Total uronic acid was also significantly reduced in the brains of treated mice. The level of a disaccharide marker (hexosamine-N-sulphate[alpha-1,4]hexuronic acid; HNS-UA) of heparan sulphate storage was also decreased in the brains of treated mice, albeit non-significantly. These results suggest that lentiviral-mediated somatic gene transfer may affect not only the somatic, but possibly also the CNS pathology, found in MPS IIIA. |
Keywords: | Liver Spleen Lysosomes Animals Mice Lentivirus Mucopolysaccharidosis III Disease Models, Animal Uronic Acids Hydrolases Disaccharides Spectrometry, Mass, Electrospray Ionization Brain Chemistry Genetic Vectors Male Tandem Mass Spectrometry beta-N-Acetylhexosaminidases Genetic Therapy |
DOI: | 10.1016/j.ymgme.2007.11.008 |
Description (link): | http://www.elsevier.com/wps/find/journaldescription.cws_home/622920/description#description |
Published version: | http://dx.doi.org/10.1016/j.ymgme.2007.11.008 |
Appears in Collections: | Aurora harvest Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.